Clinical trials
Acute Kidney Disease clinical trials
Below are recruiting acute kidney disease clinical trials, each written for real people, not researchers. We’re tracking 305 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07549243Recruiting
Ear Nerve Stimulation to Protect Kidneys During Heart Surgery
This trial tests whether gentle electrical stimulation applied to your ear can help protect your kidneys during heart surgery that uses a heart-lung machine. Kidney damage after this type of surgery is common, and researchers want to see if this non-invasive stimulation can prevent it.
Hangzhou, ZhejiangAges 18 years+ - NCT07351149Recruiting
Study on kidney injury after major surgery in children
This trial looks at how often children develop kidney problems after major surgery that isn't on the heart or kidneys. The goal is to learn more about these injuries and how to prevent them.
Perth, Western AustraliaAges birth–16 years - NCT05147831Recruiting
Remote arm treatment to prevent kidney injury from contrast dye
This trial tests whether a simple “arm conditioning” technique done remotely before a procedure can help prevent kidney injury caused by contrast dye used during certain heart catheter tests. You might benefit if you’re having a coronary angiogram and your kidney function is reduced, but you’re not on dialysis.
Galveston, TexasAges 18 years+ - NCT07030166Recruiting
Predicting kidney injury risk after non-cardiac surgery
This trial uses machine learning to predict the risk of acute kidney injury (AKI) after non-cardiac surgery. If you are 18 or older and having this type of surgery, it may help understand your risk and guide care.
NanjingAges 18 years+ - NCT07494409RecruitingPhase 3
A new oral medicine for anemia in dialysis patients
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
ShanghaiAges 18–75 - NCT06706258RecruitingPhase 2
Preventing kidney injury after heart surgery with a stomach acid drug
This trial tests whether giving a common stomach acid medication (a proton pump inhibitor) before, during, and after heart surgery can help prevent acute kidney injury. If you are at moderate to high risk for kidney problems after surgery, this study may be a good fit.
Houston, TexasAges 18–90 - NCT05879432RecruitingPhase 2
Peptide treatment to prevent or lessen kidney injury after heart surgery
This Phase 2 trial tests an LSALT peptide given around the time of “on-pump” heart surgery to help prevent or reduce acute kidney injury (a sudden drop in kidney function). It may help people who are at higher risk for kidney injury during or after surgery.
Calgary, AlbertaAges 18 years+ - NCT06374277Recruiting
Pharmacy Coaching to Help After Hospital Stay
This study tests a program where a pharmacist helps you manage your medications after you leave the hospital. It is for people with long-term health conditions who want to stay on track with their medicines.
Knoxville, TennesseeAges 18 years+ - NCT03945968Recruiting
Risk scores after abdominal surgery for people with health conditions
This study looks at how other health problems affect the chance of postoperative complications after abdominal surgery. It aims to help doctors better predict risk and decide on the safest care for you.
ArkhangelskAges 18 years+ - NCT07037485Recruiting
Predicting kidney injury after open heart surgery
This trial tests if kidney ultrasound and urine oxygen levels can predict acute kidney injury after open heart surgery. It aims to help doctors catch kidney problems early.
Tanta, El-GharbiaAges 21 years+ - NCT06801886Enrolling by invitationPhase 3
Silymarin for better kidney transplant success
This trial tests if adding silymarin (a milk thistle extract) to standard anti-rejection medicines helps protect the new kidney from damage. It may improve how well the transplanted kidney works over time.
MartinAges Any age - NCT03629418Recruiting
Blood-pressure strategy to prevent kidney injury after heart bypass
This trial tests a targeted way to manage blood pressure before and after off-pump heart bypass surgery, with the goal of reducing acute kidney injury (sudden kidney problems). It may help some people by lowering stress on the kidneys during and right after surgery.
Beijing, Beijing MunicipalityAges 50 years+ - NCT07258875Recruiting
Using ultrasound to guide fluids during lung surgery
This study tests if using a special ultrasound exam (VExUS) to guide fluid management during lung surgery can help reduce complications like lung problems or kidney injury. It may help doctors give you just the right amount of fluids.
Heraklion, CreteAges 18 years+ - NCT06954129RecruitingPhase 4
Comparing two antibiotic combos for infection and kidney safety
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06772025Recruiting
Understanding kidney injury after heart surgery with heart-lung machine
This study looks at why some people develop kidney damage after heart surgery that uses a heart-lung machine. It aims to help doctors better predict and prevent this complication.
Bad Oeynhausen, North Rhine-WestphaliaAges 18 years+ - NCT06013865RecruitingPhase 4
Empagliflozin for kidney transplant recipients
This trial tests if empagliflozin, a diabetes medicine that also protects the kidneys, can help people who have received a kidney transplant. It may be an option if you have reduced kidney function or diabetes after transplant.
Hines, IllinoisAges 19 years+ - NCT07403669Recruiting
Heart, kidney, and metabolic health assessment study
This trial offers a health assessment and empowerment program for adults who have heart, kidney, or metabolic conditions like diabetes or heart disease. It aims to help you better manage your health.
Chandler, ArizonaAges 18 years+ - NCT04671771Recruiting
Testing a new graft for hemodialysis access in kidney failure
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Phoenix, ArizonaAges 18–90 - NCT07368712Recruiting
Study of kidney function in healthy people and those with kidney issues
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
BerlinAges 18–75 - NCT07207031Enrolling by invitation
Kidney injury in ICU patients: a study
This study tracks how often kidney problems occur in ICU patients. By watching your kidney function during your stay, researchers hope to better understand and prevent kidney injury in critically ill people.
GhentAges 18 years+ - NCT04442516Recruiting
Testing kidney injury risk from cisplatin cancer treatment
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
London, OntarioAges 3 months+ - NCT07710183Recruiting
Pumpkin seed oil for hemodialysis patients
This study tests if pumpkin seed oil, a natural supplement, can improve health in people on long-term dialysis. It may help with inflammation and nutrition without using prescription drugs.
Baghdad, KarkhAges 18 years+ - NCT07683975RecruitingPhase 4
Infliximab for kidney injury caused by immunotherapy
This study tests whether infliximab can treat kidney damage caused by immune checkpoint inhibitor cancer therapy. It aims to see if this medication helps patients recover kidney function after injury from their cancer treatment.
Boston, MassachusettsAges 18 years+ - NCT07224776RecruitingPhase 1
Sparsentan for proteinuria from VEGF inhibitor cancer treatment
This trial tests if sparsentan can reduce high levels of protein in the urine caused by VEGF signaling pathway inhibitors (VSPIs), a type of cancer treatment. It may help protect kidney function during cancer therapy.
Boston, MassachusettsAges 18 years+
Hear when a new Acute Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute kidney disease?
- Yes. Clin2 currently lists 305 recruiting acute kidney disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute kidney disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute kidney disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.